This learning module explores patient education and the issues of continuity of care associated with non-Hodgkin lymphoma, as well as treatment options. Chemotherapy, radiotherapy and stem cell transplantation are the main treatment modalities for this heterogeneous group of lymphoproliferative malignancies, but targeted therapies such as the use of monoclonal antibodies are also highlighted.
Please note that information provided by RCNi Learning is not sufficient to ensure competence in the skill. Assessment of competence should take place in line with local practice. Practice should always align with local protocols and procedures, latest guidelines and any regulatory code. All modules should currently be viewed together with available national and local Covid-19 guidelines. For advice, go to www.rcn.org.uk/covid-19
Unlock full access to RCNi Plus today
SAVE OVER 50% ON YOUR FIRST 3 MONTHS
- You may cancel at any time -
All our modules include CPD certificates. They are evidence-based and have been subject to an external double-blind peer review.
Personal revalidation RCNi Revalidation Portfolio to document learning. Download as a PDF to submit to the NMC
Log CPD hours, write a reflective account and save certificate into RCNi Revalidation Portfolio
Pre and post module tests let you measure your progress. Further reading list included